Symptom management in end-stage CKD

June 9, 2026

This eBook from Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Julissa Clay , Shelly Manning , Jodi Knapp and Scott Davis.

Symptom management in end-stage CKD

End-stage chronic kidney disease (ESKD), also referred to as stage 5 CKD or end-stage renal disease (ESRD), represents the most advanced phase of kidney dysfunction. At this point, kidney function has declined to less than 15% of normal capacity, leaving patients unable to maintain fluid, electrolyte, and metabolic balance without renal replacement therapy such as dialysis or kidney transplantation. While dialysis can prolong life, many patients still experience a significant burden of symptoms that negatively impact their quality of life. For those who are not candidates for transplantation or who decline dialysis, symptom management becomes the cornerstone of care.

Patients with ESKD often experience a wide spectrum of symptoms, including pain, fatigue, pruritus, dyspnea, sleep disturbances, depression, and gastrointestinal issues. These symptoms result from both the underlying pathophysiology of kidney failure and the complications associated with treatment. Addressing them requires a multidisciplinary, patient-centered approach that incorporates pharmacological therapies, lifestyle modifications, psychological support, and palliative interventions.

This essay explores the principles, challenges, and strategies of symptom management in end-stage CKD, highlighting the importance of comprehensive care in improving comfort, dignity, and quality of life.


1. Understanding the Symptom Burden in End-Stage CKD

1.1 Prevalence of Symptoms

Research demonstrates that patients with ESKD experience as many, if not more, symptoms as individuals with advanced cancer or heart failure. Commonly reported symptoms include:

  • Pain (experienced by 50–70% of patients)

  • Fatigue and weakness

  • Uremic pruritus (itching)

  • Nausea and vomiting

  • Restless legs syndrome

  • Sleep disturbances

  • Dyspnea due to fluid overload or anemia

  • Cognitive impairment or “brain fog”

  • Anxiety and depression

1.2 Impact on Quality of Life

These symptoms significantly affect daily functioning, emotional well-being, and social interactions. Without adequate management, they can lead to increased hospitalizations, caregiver burden, and diminished quality of life.


2. Principles of Symptom Management in End-Stage CKD

2.1 Patient-Centered Care

Management must prioritize the patient’s goals, preferences, and values. Some may wish to focus on prolonging survival, while others may prioritize comfort and symptom relief.

2.2 Interdisciplinary Approach

Effective management requires collaboration among nephrologists, nurses, dietitians, social workers, psychologists, and palliative care specialists.

2.3 Individualized Treatment

Because CKD alters drug metabolism and excretion, pharmacological treatments must be carefully selected and dosed to avoid toxicity.

2.4 Holistic Framework

Symptom management should address not only physical complaints but also psychological, social, and spiritual dimensions of suffering.


3. Management of Common Symptoms

3.1 Pain

Causes

Pain in ESKD may arise from comorbid conditions (such as diabetes, arthritis, or vascular disease), neuropathy, bone disease, or complications of dialysis access.

Management

  • Non-Pharmacological Approaches: Physical therapy, massage, heat/cold application, relaxation techniques.

  • Pharmacological Approaches:

    • Acetaminophen is considered safe for mild to moderate pain.

    • Non-steroidal anti-inflammatory drugs (NSAIDs) are generally avoided due to nephrotoxicity and gastrointestinal risks, but may be cautiously used in patients already on dialysis.

    • Opioids: Fentanyl and methadone are preferred due to safer renal clearance, while morphine and codeine should be avoided. Dose adjustments are crucial to avoid accumulation and toxicity.


3.2 Fatigue

Causes

Fatigue is multifactorial, resulting from anemia, uremia, malnutrition, sleep disturbances, and depression.

Management

  • Correcting Anemia: Use of erythropoiesis-stimulating agents (ESAs) and iron supplementation.

  • Optimizing Nutrition: Addressing protein-energy wasting with dietitian support.

  • Physical Activity: Light exercise such as walking or yoga to enhance energy.

  • Psychological Support: Addressing depression or anxiety through counseling or medications.


3.3 Pruritus (Uremic Itch)

Causes

Pruritus is a common and distressing symptom in ESKD, often linked to uremia, imbalances in calcium and phosphorus, or systemic inflammation.

Management

  • Topical Treatments: Emollients, menthol creams.

  • Pharmacological Treatments: Antihistamines have limited benefit; gabapentin or pregabalin are often more effective.

  • Phototherapy: Narrow-band UVB therapy may help refractory cases.

  • Dialysis Optimization: Improving adequacy of dialysis can reduce pruritus in some patients.


3.4 Dyspnea

Causes

Breathlessness may be caused by fluid overload, pulmonary edema, anemia, or metabolic acidosis.

Management

  • Fluid Management: Strict fluid and sodium restriction, diuretics if residual kidney function exists, or dialysis adjustments.

  • Oxygen Therapy: To relieve hypoxemia.

  • Pharmacological Measures: Low-dose opioids may relieve the sensation of breathlessness.

  • Positioning: Elevating the head of the bed and using fans for airflow.


3.5 Nausea and Vomiting

Causes

Often due to uremia, gastroparesis, or side effects of medications such as phosphate binders.

Management

  • Pharmacological:

    • Metoclopramide for gastroparesis.

    • Ondansetron or haloperidol for uremia-related nausea.

  • Non-Pharmacological: Smaller, frequent meals, avoiding foods that exacerbate symptoms.


3.6 Sleep Disturbances and Restless Legs Syndrome (RLS)

Causes

RLS and insomnia are prevalent in CKD, related to uremia, anemia, and electrolyte disturbances.

Management

  • Sleep Hygiene: Consistent sleep schedule, reducing caffeine.

  • Pharmacological: Dopamine agonists, gabapentin, or clonazepam may be considered.

  • Addressing Underlying Causes: Correcting anemia and optimizing dialysis.


3.7 Depression and Anxiety

Causes

Chronic illness, loss of independence, and treatment burden contribute to emotional distress.

Management

  • Psychological Interventions: Counseling, cognitive-behavioral therapy (CBT), mindfulness.

  • Pharmacological: Selective serotonin reuptake inhibitors (SSRIs) are generally considered safe with dose adjustments.

  • Support Systems: Encouraging family and peer support, connecting patients with support groups.


3.8 Cognitive Impairment

Causes

Uremic toxins, anemia, and vascular disease can contribute to cognitive decline in ESKD.

Management

  • Optimizing dialysis adequacy.

  • Treating anemia.

  • Cognitive training exercises and caregiver education.


4. Non-Pharmacological Interventions

  • Dietary Modifications: Restricting sodium, phosphorus, and potassium to alleviate symptoms and reduce complications.

  • Fluid Restriction: To prevent edema and breathlessness.

  • Physical Therapy: Gentle exercises to maintain mobility and reduce fatigue.

  • Complementary Therapies: Acupuncture, meditation, and relaxation techniques may provide additional relief.


5. The Role of Palliative Care in Symptom Management

5.1 Integration with Nephrology

Palliative care should be integrated early in the disease trajectory to help manage symptoms alongside disease-directed treatments.

5.2 Advance Care Planning

Discussions about prognosis, treatment preferences, and end-of-life care should be initiated early to ensure patient-centered decision-making.

5.3 Hospice Care

For patients who discontinue dialysis or are not candidates, hospice care provides comfort-focused management, emphasizing dignity and quality of life in the final phase.


6. Challenges in Symptom Management

6.1 Polypharmacy and Drug Toxicity

Altered pharmacokinetics in ESKD complicates safe prescribing. Close monitoring is essential.

6.2 Underreporting of Symptoms

Patients may underreport symptoms due to normalization of discomfort or fear of burdening healthcare providers.

6.3 Limited Resources

Access to palliative care and psychosocial support varies across regions, creating disparities in care.

6.4 Cultural and Individual Differences

Beliefs about pain, suffering, and end-of-life care influence symptom reporting and treatment acceptance.


7. Case Example

A 68-year-old patient with ESKD on dialysis presents with severe fatigue, itching, and depression. A multidisciplinary approach is employed: ESAs and iron supplementation for anemia, gabapentin for pruritus, and counseling for depression. Fluid management strategies alleviate dyspnea, while spiritual counseling addresses existential concerns. Over time, the patient experiences improved comfort and emotional well-being, illustrating the value of comprehensive, individualized symptom management.


8. Future Directions

8.1 Research

More clinical trials are needed to evaluate the efficacy of symptom management strategies in CKD, particularly in non-dialysis patients.

8.2 Education

Healthcare providers require training in palliative nephrology to better address complex symptom burdens.

8.3 Policy

Policies should promote integration of palliative care into standard nephrology practice and improve access to resources for underserved populations.

8.4 Patient Empowerment

Encouraging patients to participate in symptom reporting and shared decision-making ensures care remains patient-centered.


Conclusion

Symptom management in end-stage CKD is a critical aspect of care that goes beyond dialysis and transplantation. Patients face a broad range of physical, emotional, and psychosocial symptoms that profoundly impact their quality of life. Through patient-centered, multidisciplinary, and holistic approaches, clinicians can significantly reduce suffering, enhance dignity, and promote well-being. Integrating palliative care, optimizing pharmacological and non-pharmacological strategies, and supporting families and caregivers are essential to effective management. As CKD prevalence continues to rise, improving symptom control will remain a vital priority in nephrology and end-of-life care.

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.


Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Shelly Manning Jodi Knapp and Scott Davis.

About Christian Goodman

Christian Goodman is the CEO of Blue Heron Health News. He was born and raised in Iceland, and challenges have always been a part of the way he lived. Combining this passion for challenge and his obsession for natural health research, he has found a lot of solutions to different health problems that are rampant in modern society. He is also naturally into helping humanity, which drives him to educate the public on the benefits and effectiveness of his natural health methods.

For readers interested in natural wellness approaches, mr.Hotsia is a longtime traveler who has expanded his interests into natural health education and supportive lifestyle-based ideas. He also recommends exploring the natural health books and wellness resources published by Blue Heron Health News, along with works from well-known natural wellness authors such as Julissa Clay, Christian Goodman, Jodi Knapp, Shelly Manning, and Scott Davis. Explore these authors to discover a wide range of natural wellness insights, supportive strategies, and educational resources for everyday health concerns.

Mr.Hotsia

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. I share my experiences on www.hotsia.com